Millipore Sigma Vibrant Logo

531000 Brk Inhibitor, Cpd 4f - Calbiochem

A cell permeable, highly potent, and very selective inhibitor of breast tumor kinase (Brk; IC₅₀ = 3.15 nM). Displays anti-proliferative activity against multiple breast cancer cell lines.

Brk Inhibitor, Cpd 4f - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: PTK6 Inhibitor, Breast Tumor Kinase Inhibitor

Primary Target: Brk
View This Product on Sigma-Aldrich
531000
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

Empirical Formula
C₁₇H₁₃N₃O

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
5.31000.0001
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 ｶﾞﾗｽﾋﾞﾝ 10 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA cell permeable pyridoindole based compound that acts as a highly potent and selective inhibitor of breast tumor kinase (Brk; IC50 = 3.15 nM) with minimal or no effect against a panel of more than 30 other protein kinases (IC50 = < 10 µM for PIM2, NEK1 and2, CAMK4, MAPKAPK3 and 5 and MARK1, 3, and 5). Does not affect the activity of Akt isoforms, AGC kinases, ERK1 and 2, JNK 1 and 2 and HIPK isoforms. Displays anti-proliferative activity against multiple breast cancer cell lines (GI50 = 990 nM; 1.02 µM, and 1.58 µM for MCF7, HS-578/T, BT-549, respectively).

      Please note that the molecular weight for this compound is batch-specific due to variable water content.
      Catalogue Number531000
      Brand Family Calbiochem®
      SynonymsPTK6 Inhibitor, Breast Tumor Kinase Inhibitor
      References
      ReferencesMahmoud, K. A., et al. 2014. Bioorg. Med. Chem. Lett. 24, 1948.
      Product Information
      FormLight beige powder
      Hill FormulaC₁₇H₁₃N₃O
      Chemical formulaC₁₇H₁₃N₃O
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetBrk
      Primary Target IC<sub>50</sub>3.15 nM
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are good for up to 2 weeks at -70°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      5.31000.0001 04055977242485

      Documentation

      Brk Inhibitor, Cpd 4f - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      参考資料

      参考資料の概要
      Mahmoud, K. A., et al. 2014. Bioorg. Med. Chem. Lett. 24, 1948.

      カタログ

      タイトル
      NPI Flyer- Epigenetics and Nuclear Function Feature
      New Products - Antibodies, Small Molecule, Inhibitors

      技術情報

      タイトル
      White Paper: Further considerations of antibody validation and usage.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision19-September-2014 JSW
      SynonymsPTK6 Inhibitor, Breast Tumor Kinase Inhibitor
      DescriptionA cell permeable pyridoindole based compound that acts as a highly potent and selective inhibitor of breast tumor kinase (Brk; IC50 = 3.15 nM) with minimal or no effect against a panel of more than 30 other protein kinases (IC50 = < 10 µM for PIM2, NEK1 and2, CAMK4, MAPKAPK3 and 5 and MARK1, 3, and 5). Does not affect the activity of Akt isoforms, AGC kinases, ERK1 and 2, JNK 1 and 2 and HIPK isoforms. Displays anti-proliferative activity against multiple breast cancer cell lines (GI50 = 990 nM; 1.02 µM, and 1.58 µM for MCF7, HS-578/T, BT-549, respectively).
      FormLight beige powder
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₁₇H₁₃N₃O
      Purity≥97% by HPLC
      SolubilityDMSO (100 mg/ml). Use only fresh DMSO for reconstitution.
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are good for up to 2 weeks at -70°C.
      Toxicity Standard Handling
      ReferencesMahmoud, K. A., et al. 2014. Bioorg. Med. Chem. Lett. 24, 1948.